The UK should abolish National Health Service prescriptions, except forthe poor and the chronically ill, as the current system under which most prescription items are supplied free with only a minority of people paying a charge is pointless and wasteful, says an essay in a new report on drug price regulation, published by the Institute of Economic Affairs.
The essay, by Duncan Reekie of the University of the Witwatersrand University, South Africa, says each UK consumer receives 9.5 prescriptions a year on average, covering drugs worth just under L87 ($147.68). Most people could easily pay for this themselves, and it would be more efficient to allow them to do so, he says.
The report, Should Pharmaceutical Prices Be Regulated? mainly assesses the rationale of the Pharmaceutical Price Regulation Scheme, which is due to be re-negotiated in 1998. It states that, like all government attempts to regulate industry, the PPRS distorts the industry it regulates. By hindering price flexibility it prevents suppliers from trying out different pricing strategies to establish demand, and by fixing the amounts allowed for R&D in calculating profits, it can either restrict R&D by allowing too little, or encourage wastefulness by allowing too much.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze